Small Pharma Inc. (DMTTF)
- GlobeNewswire
Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry
LONDON, March 07, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, today announces that it will host a virtual Key Opinion Leader roundtable with Jerry Rosenbaum, MD, Professor of Psychiatry at Harvard Medical School, and David Erritzoe, MD, PhD, Imperial College London on Wednesday, March 15, 2023 at 2:00 p.m. EDT. Dr. Carol Routl
- GlobeNewswire
Small Pharma Announces Further Positive Data from SPL026 Phase IIa Trial in Major Depressive Disorder Strengthening Topline Efficacy Results
Small Pharma Inc. Phase IIa Trial Data Small Pharma Inc. Phase IIa Trial Data -Patients’ self-reported depression and wellbeing scores corroborate MADRS efficacy data-Statistically significant improvement in anxiety symptoms offers potential in new indications beyond depression LONDON, March 07, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health
- GlobeNewswire
Small Pharma to Present at Cowen’s 43rd Annual Health Care Conference
Company will also host a cocktail reception on Tuesday, March 7LONDON, March 01, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, is pleased to announce that George Tziras, Chief Executive Officer and Dr. Carol Routledge, Chief Medical and Scientific Officer, will participate in Cowen’s 43rd Annual Health Care Conference, taking pl
